Related Experiment Video
Updated: Jul 6, 2026
Assessment of Vascular Regeneration in the CNS Using the Mouse Retina
Published on: June 23, 2014
Tanshinone IIA inhibits choroidal neovascularization and restores outer blood-retinal barrier function in Vldlr
Pinghui Wei1, Shan Gao2, Keting Zhang2
1Tianjin Eye Hospital, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin, 300020, PR China; Nankai University Affiliated Eye Hospital, Nankai University Eye Institute, Nankai University, Tianjin, 300350, PR China; Clinical College of Ophthalmology, Tianjin Medical University, Tianjin, 300020, PR China.
Tanshinone IIA (TIIA) effectively treats wet age-related macular degeneration (AMD) by reducing abnormal blood vessel growth and restoring barrier integrity. This compound shows promise as an alternative therapy for AMD, addressing challenges with current treatments.
Area of Science:
- Ophthalmology
- Pharmacology
- Molecular Biology
Background:
- Neovascular age-related macular degeneration (nAMD) causes vision loss, with anti-VEGF treatments facing resistance.
- Tanshinone IIA (TIIA), from Salvia miltiorrhiza, is explored for retinal disease potential.
Purpose of the Study:
- To investigate TIIA's therapeutic effects on choroidal neovascularization (CNV) in an nAMD mouse model.
- To elucidate the molecular mechanisms underlying TIIA's action in nAMD.
Main Methods:
- Utilized Vldlr knockout mice as an nAMD model, administering TIIA intraperitoneally for 8 weeks.
- Evaluated CNV progression and leakage using OCT and FFA; assessed outer blood-retinal barrier (oBRB) integrity via immunofluorescence.
- Employed proteomics and western blotting to explore molecular pathways.
Main Results:
- TIIA significantly reduced CNV area and vascular leakage, restoring oBRB integrity by upregulating ZO-1 and Occludin.
- TIIA inhibited angiogenesis by suppressing the PLCγ/ERK1/2 signaling pathway.
- Proteomics revealed TIIA enhanced cholesterol efflux, reorganized intermediate filaments, and decreased autophagy proteins.
Conclusions:
- TIIA demonstrates significant therapeutic potential for nAMD by targeting multiple pathways.
- Mechanisms include anti-angiogenesis, barrier restoration, metabolic reprogramming, and autophagy modulation.
- TIIA offers a promising alternative therapeutic strategy for nAMD, overcoming current treatment limitations.
